A Study of Duvelisib in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ Follicular Lymphoma (CONTEMPO)
Clinical trial NCT02391545 · TERMINATED
Trial details
- NCT number
- NCT02391545
- Sponsor
- SecuraBio
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-01-17
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.